LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

Search

Stryker Corp

Geschlossen

BrancheGesundheitswesen

353.66 -1.02

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

349.18

Max

357.3

Schlüsselkennzahlen

By Trading Economics

Einkommen

-25M

859M

Verkäufe

35M

6.1B

KGV

Branchendurchschnitt

47.188

77.256

EPS

3.19

Dividendenrendite

0.94

Gewinnspanne

14.182

Angestellte

53,000

EBITDA

-108M

1.4B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+20.39% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.94%

2.33%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-9.7B

137B

Vorheriger Eröffnungskurs

354.68

Vorheriger Schlusskurs

353.66

Nachrichtenstimmung

By Acuity

45%

55%

157 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Stryker Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

30. Okt. 2025, 20:36 UTC

Ergebnisse

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

31. Juli 2025, 20:42 UTC

Ergebnisse

Stryker Lifts Guidance on Improving Tariff Outlook

1. Mai 2025, 20:56 UTC

Ergebnisse

Stryker Lowers Adjusted EPS View on $200 Million Tariff Impact

5. Nov. 2025, 19:38 UTC

Ergebnisse

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5. Nov. 2025, 17:00 UTC

Ergebnisse

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30. Okt. 2025, 20:21 UTC

Ergebnisse

Stryker Lifts FY Sales View After 3Q Revenue Rises

30. Okt. 2025, 20:05 UTC

Ergebnisse

Stryker 3Q Adj EPS $3.19 >SYK

30. Okt. 2025, 20:05 UTC

Ergebnisse

Stryker 3Q EPS $2.22 >SYK

30. Okt. 2025, 20:05 UTC

Ergebnisse

Stryker 3Q Sales $6.1B >SYK

30. Okt. 2025, 20:05 UTC

Ergebnisse

Stryker 3Q Net $859M >SYK

30. Okt. 2025, 20:05 UTC

Ergebnisse

Stryker Sees FY Adj EPS $13.50-Adj EPS $13.60 >SYK

30. Okt. 2025, 20:05 UTC

Ergebnisse

Stryker 3Q Adj EPS $3.19 >SYK

30. Okt. 2025, 20:05 UTC

Ergebnisse

Stryker 3Q Net $859M >SYK

30. Okt. 2025, 20:05 UTC

Ergebnisse

Stryker 3Q Sales $6.06B >SYK

30. Okt. 2025, 20:05 UTC

Ergebnisse

Stryker 3Q EPS $2.22 >SYK

31. Juli 2025, 20:09 UTC

Ergebnisse

Stryker Estimates Net Impact From Tariffs in 2025 of Approximately $175M

31. Juli 2025, 20:09 UTC

Ergebnisse

Stryker Sales >SYK

31. Juli 2025, 20:09 UTC

Ergebnisse

Stryker Sees FY25 Organic Net Sales Up 9.5%-10%

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q Sales $6B >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q Net $884M >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker Sees FY Adj EPS $13.40-Adj EPS $13.60 >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q EPS $2.29 >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q Adj EPS $3.13 >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q Sales $6B >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q EPS $2.29 >SYK

31. Juli 2025, 20:05 UTC

Ergebnisse

Stryker 2Q EPS $2.29 >SYK

1. Mai 2025, 20:41 UTC

Ergebnisse

Stryker Lowers Adjusted EPS View on $200M Tariff Impact

1. Mai 2025, 20:11 UTC

Ergebnisse

Stryker Cuts FY25 View To Adj EPS $13.20-Adj EPS $13.45 >SYK

1. Mai 2025, 20:10 UTC

Ergebnisse

Stryker Raising FY25 Organic Net Sales Growth Guidance Range to 8.5% to 9.5% >SYK

1. Mai 2025, 20:05 UTC

Ergebnisse

Stryker 1Q Adj EPS $2.84 >SYK

Peer-Vergleich

Kursveränderung

Stryker Corp Prognose

Kursziel

By TipRanks

20.39% Vorteil

12-Monats-Prognose

Durchschnitt 430.6 USD  20.39%

Hoch 455 USD

Tief 392 USD

Basierend auf 15 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Stryker Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

15 ratings

12

Buy

3

Halten

0

Sell

Technischer Score

By Trading Central

373.92 / 383.99Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Stimmung

By Acuity

157 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat